Canada markets close in 1 hour 33 minutes

Fennec Pharmaceuticals Inc. (FRX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
12.800.00 (0.00%)
As of 01:16PM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 346.88M
Enterprise Value 371.11M
Trailing P/E N/A
Forward P/E 30.30
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.65
Price/Book (mrq)84.57
Enterprise Value/Revenue 17.46
Enterprise Value/EBITDA -30.02

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 321.10%
S&P500 52-Week Change 325.01%
52 Week High 315.43
52 Week Low 39.27
50-Day Moving Average 313.48
200-Day Moving Average 312.10

Share Statistics

Avg Vol (3 month) 3362
Avg Vol (10 day) 3300
Shares Outstanding 527.1M
Implied Shares Outstanding 627.1M
Float 815.29M
% Held by Insiders 114.60%
% Held by Institutions 155.23%
Shares Short (Apr 15, 2024) 474.89k
Short Ratio (Apr 15, 2024) 4273.34
Short % of Float (Apr 15, 2024) 40.39%
Short % of Shares Outstanding (Apr 15, 2024) 40.28%
Shares Short (prior month Mar 15, 2024) 474.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Sept 05, 2014

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -75.50%
Operating Margin (ttm)-18.67%

Management Effectiveness

Return on Assets (ttm)-29.67%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)21.25M
Revenue Per Share (ttm)0.80
Quarterly Revenue Growth (yoy)534.20%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-16.05M
Diluted EPS (ttm)-0.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.27M
Total Cash Per Share (mrq)0.49
Total Debt (mrq)30.95M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.56
Book Value Per Share (mrq)-0.43

Cash Flow Statement

Operating Cash Flow (ttm)-17.14M
Levered Free Cash Flow (ttm)-12.35M